Key Takeaways
- • Benchmark Genetics appoints Thomas Samdal as chief financial officer effective April 1, 2026, replacing retiring CFO Jon Crowther following a transition period.
- • Samdal brings nearly 20 years of experience in auditing, corporate finance, and financial leadership, including exposure to private equity-backed companies, and holds advanced degrees in economics and accounting from Norwegian School of Economics.
- • Samdal joins from NORCE research institute, where he served as CFO overseeing finance, reporting, financing, and sustainability reporting functions.
- • Benchmark Genetics operates breeding programmes for Atlantic salmon and provides genetics and genotyping services across 50+ countries; the company became independent under Novo Holdings ownership in the prior year.
Summary
Benchmark Genetics has strengthened its financial leadership with the appointment of Thomas Samdal as chief financial officer, effective April 1, 2026. The move follows the planned retirement of Jon Crowther, with Samdal's onboarding supported by a transition period to ensure continuity of the finance function.
Samdal brings substantial financial management experience to the role, with nearly two decades of professional background spanning auditing, corporate finance, and financial leadership. His educational credentials include a Master of Science in Economics and Business Administration from Norwegian School of Economics and a Master in Accounting and Auditing. Prior to joining Benchmark Genetics, Samdal served as CFO at NORCE, a research institute where he held responsibility for the organization's finance function, including financial reporting, financing strategy, and sustainability reporting—areas increasingly material to aquaculture stakeholders.
Benchmark Genetics operates breeding programmes for Atlantic salmon and delivers genetics and genotyping services to aquaculture producers in more than 50 countries. The company transitioned to independent status under the ownership of Novo Holdings during the prior year, a structural change that coincides with the CFO appointment and suggests potential strategic positioning around financial optimization and stakeholder communication.
Samdal's background in private equity-backed companies aligns with Benchmark Genetics' current ownership structure and may signal attention to operational efficiency and financial discipline under institutional ownership. His experience with sustainability reporting is particularly relevant given the aquaculture sector's heightened focus on environmental and governance metrics.
Samdal brings substantial financial management experience to the role, with nearly two decades of professional background spanning auditing, corporate finance, and financial leadership. His educational credentials include a Master of Science in Economics and Business Administration from Norwegian School of Economics and a Master in Accounting and Auditing. Prior to joining Benchmark Genetics, Samdal served as CFO at NORCE, a research institute where he held responsibility for the organization's finance function, including financial reporting, financing strategy, and sustainability reporting—areas increasingly material to aquaculture stakeholders.
Benchmark Genetics operates breeding programmes for Atlantic salmon and delivers genetics and genotyping services to aquaculture producers in more than 50 countries. The company transitioned to independent status under the ownership of Novo Holdings during the prior year, a structural change that coincides with the CFO appointment and suggests potential strategic positioning around financial optimization and stakeholder communication.
Samdal's background in private equity-backed companies aligns with Benchmark Genetics' current ownership structure and may signal attention to operational efficiency and financial discipline under institutional ownership. His experience with sustainability reporting is particularly relevant given the aquaculture sector's heightened focus on environmental and governance metrics.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.